PL357490A1 - Sposób wytwarzania bezpostaciowej soli wapniowej aSposób wytwarzania bezpostaciowej soli wapniowej atorwastatynytorwastatyny - Google Patents
Sposób wytwarzania bezpostaciowej soli wapniowej aSposób wytwarzania bezpostaciowej soli wapniowej atorwastatynytorwastatynyInfo
- Publication number
- PL357490A1 PL357490A1 PL02357490A PL35749002A PL357490A1 PL 357490 A1 PL357490 A1 PL 357490A1 PL 02357490 A PL02357490 A PL 02357490A PL 35749002 A PL35749002 A PL 35749002A PL 357490 A1 PL357490 A1 PL 357490A1
- Authority
- PL
- Poland
- Prior art keywords
- calcium salt
- obtaining amorphous
- atorvastatine
- atorvastatine calcium
- amorphous
- Prior art date
Links
- -1 atorvastatine calcium salt Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN472MU2002 | 2002-05-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL357490A1 true PL357490A1 (pl) | 2003-12-01 |
Family
ID=29560492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02357490A PL357490A1 (pl) | 2002-05-28 | 2002-12-02 | Sposób wytwarzania bezpostaciowej soli wapniowej aSposób wytwarzania bezpostaciowej soli wapniowej atorwastatynytorwastatyny |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2002356423A1 (pl) |
| PL (1) | PL357490A1 (pl) |
| WO (1) | WO2003099785A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL156055A0 (en) * | 2000-11-30 | 2003-12-23 | Teva Pharma | Novel crystal forms of atorvastatin hemi calcium and processes for their preparation as well as novel processes for preparing other forms |
| CA2666359A1 (en) | 2004-03-17 | 2005-10-06 | Yatendra Kumar | Process for the production of atorvastatin calcium in amorphous form |
| EP1711464A2 (en) * | 2004-07-22 | 2006-10-18 | Teva Pharmaceutical Industries Ltd | Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation |
| WO2006021969A1 (en) * | 2004-08-27 | 2006-03-02 | Biocon Limited | Process for atorvastatin calcium amorphous |
| CA2582087A1 (en) * | 2004-10-18 | 2006-04-27 | Teva Pharmaceutical Industries Ltd. | Process for preparing amorphous atorvastatin hemi-calcium by dissolving the salt in an organic solvent which is a mixture of an alcohol and a ketone and/or an ester and removing the solvent |
| EP2075246A1 (en) | 2007-12-27 | 2009-07-01 | M. J. Institute of Research | A process for preparation of amorphous form of atorvastatin hemi-calcium salt |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP960312B1 (en) * | 1995-07-17 | 2001-10-31 | Warner Lambert Co | NOVEL PROCESS FOR THE PRODUCTION OF AMORPHOUS /R-(R*, R*)/-2-(4-FLUOROPHENYL)-"beta", "delta"-DIHYDROXY-5-PHENYL-4-/(PHENYLAMINO)CARBONYL/-1H-PYRROLE -1-HEPTANOIC ACID CALCIUM SALT (2 : 1) |
| IN191236B (pl) * | 1999-05-25 | 2003-10-11 | Ranbaxy Lab Ltd | |
| HU226640B1 (en) * | 1999-10-18 | 2009-05-28 | Egis Gyogyszergyar Nyilvanosan | Process for producing amorphous atorvastatin calcium salt |
| SI20425A (sl) * | 1999-12-10 | 2001-06-30 | LEK tovarna farmacevtskih in kemi�nih izdelkov d.d. | Priprava amorfnega atorvastatina |
| IL156055A0 (en) * | 2000-11-30 | 2003-12-23 | Teva Pharma | Novel crystal forms of atorvastatin hemi calcium and processes for their preparation as well as novel processes for preparing other forms |
-
2002
- 2002-11-15 AU AU2002356423A patent/AU2002356423A1/en not_active Abandoned
- 2002-11-15 WO PCT/IN2002/000220 patent/WO2003099785A1/en not_active Ceased
- 2002-12-02 PL PL02357490A patent/PL357490A1/pl not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003099785A1 (en) | 2003-12-04 |
| AU2002356423A1 (en) | 2003-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL166626A0 (en) | Process for preparing the calcium salt of rosuvastatin | |
| AU2003291352A8 (en) | Method of securing vertebrae | |
| IL173858A0 (en) | Process for preparation of rosuvastatin calcium | |
| GB0325192D0 (en) | Method of use | |
| PL370481A1 (pl) | Sole walsartanu | |
| EP1577280A4 (en) | DEUTERATION PROCESS | |
| PL367278A1 (pl) | Sposób zapobiegania tworzeniu kamienia soli wapniowej | |
| PL367302A1 (pl) | Sposób zapobiegania tworzeniu kamienia soli wapniowej | |
| AU2002367010A1 (en) | Method of purifying brine | |
| AU2003234223A8 (en) | Method of endovascular brain mapping | |
| GB0217736D0 (en) | Method of controlling scale formation | |
| IL166600A0 (en) | Method of treating osteoarthritis | |
| HUP0300761A3 (en) | Process for the production of amorphous atorvastatin calcium | |
| PL357490A1 (pl) | Sposób wytwarzania bezpostaciowej soli wapniowej aSposób wytwarzania bezpostaciowej soli wapniowej atorwastatynytorwastatyny | |
| EP1488046A4 (en) | CONSTRUCTION METHODS | |
| AU2002258036A8 (en) | A method of making salt | |
| PL359519A1 (pl) | Sposób wytwarzania soli diketonów bicyklicznych | |
| PL359520A1 (pl) | Sposób wytwarzania cyklicznych diketonów | |
| GB0220125D0 (en) | Method of forming pocketted sponges | |
| PL355939A1 (pl) | Ulepszony sposób prowadzenia procesu krystalizacji soli cefuroksymu | |
| PL353465A1 (pl) | Sposób wytwarzania soli półwapniowej atorwastatyny w zasadniczo amorficznej postaci | |
| AU2003272327A8 (en) | Methods of bone healing | |
| PL351603A1 (en) | Method of obtaining a modified chitozane salt gel | |
| GB0213198D0 (en) | Method of treatment | |
| AU2003262803A8 (en) | Method of obtaining amorphous solid particles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |